Incyte Revenue Quarterly:
71.08M for March 31, 2013Incyte Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 71.08M |
| Dec. 31, 2012 | 113.85M |
| Sept. 30, 2012 | 60.49M |
| June 30, 2012 | 86.54M |
| March 31, 2012 | 36.18M |
| Dec. 31, 2011 | 28.89M |
| Sept. 30, 2011 | 16.78M |
| June 30, 2011 | 16.81M |
| March 31, 2011 | 31.97M |
| Dec. 31, 2010 | 85.87M |
| Sept. 30, 2010 | 16.87M |
| June 30, 2010 | 49.85M |
| March 31, 2010 | 17.29M |
| Dec. 31, 2009 | 6.866M |
| Sept. 30, 2009 | 0.939M |
| June 30, 2009 | 0.789M |
| March 31, 2009 | 0.671M |
| Dec. 31, 2008 | 0.938M |
| Sept. 30, 2008 | 1.061M |
| June 30, 2008 | 0.614M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
INCY Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| ViroPharma | 107.15M |
| Optimer Pharmaceuticals | 19.52M |
| Medivation | 37.16M |
INCY Revenue Quarterly Rankings
| Overall |
64th percentile 2720 of 7590 |
| Sector |
72nd percentile 182 of 651 in Healthcare |
| Industry |
89th percentile 24 of 238 in Biotechnology |
INCY Revenue Quarterly Range, Past 5 Years
| Minimum | 0.6140M | Jun 2008 |
| Maximum | 113.85M | Dec 2012 |
| Average | 32.22M |
